WE MAKE AQUACULTURE PROGRESS
PHARMAQ fish vaccine ALPHA JECT ® Panga 2 received Marketing Authorisation
- An important step for sustainable aquaculture in Vietnam
• ALPHA JECT ® Panga 2 has been approved by the Department of Animal Health and will be available for customers in Vietnam early 2017
• The vaccine protects against Edwardsiella ictaluri and Aeromonas hydrophila, bacterias causing significant losses in the Vietnamese pangasius industry
Ho Chi Minh City, Vietnam
December 13th, 2016
PHARMAQ's vaccine ALPHA JECT ® Panga 2 received a marketing authorisation from the Department of Animal Health December 5th 2016.
“The approval of the new vaccine is a great contribution to a more sustainable aquaculture industry in Vietnam. Behind this product are many years of research, development and documentation to ensure that the product provides a significant level of protection as well as being safe for the fish and the environment", says Pham-Cong Thanh, Country Manager PHARMAQ Vietnam.
ALPHA JECT® Panga 2 is an injection vaccine that provides protection against the main diseases in the pangasius farming industry in Vietnam, Edwardsiella ictaluri causing white spot disease and Aeromonas hydrophila causing septicimia and hemorrhage. The diseases occur during the whole production cycle and are associated with high mortalities and great economical losses.
Vaccination is an important step forward in controlling two of the major diseases in farmed pangasius in Vietnam and reduce use of antibiotics. The vaccine is well documented through field trials conducted in close cooperation with our customers over the past years.
"To achieve a more predictable and reliable fish production for pangasius, PHARMAQ aims to continuously support the Vietnamese aquaculture industry towards more advanced fish health solutions in the prevention of diseases. The approval of this vaccine is an important step towards production of safe and healthy seafood in Vietnam” says the President of PHARMAQ Morten Kr. Nordstad.
For further information, please contact:
Pham-Cong Thanh, Country Manager PHARMAQ Vietnam
E –mail: firstname.lastname@example.org
Mobile: +84 913808030
Morten Nordstad, President PHARMAQ a business of Zoetis
Telephone: +47 23 29 85 10
Mobile: +47 907 52 853
PHARMAQ is the global leader in vaccines and innovation for aquaculture and part of Zoetis, the world leader in animal health. The company provides environmentally sound, safe and efficacious health products to the global aquaculture industry through targeted research and the commitment of dedicated people. Production facilities, administration and research and development activities are based in Norway with subsidiaries in Chile, United Kingdom, Vietnam, Turkey, Spain, Panama and Hong Kong. PHARMAQ has approximately 200 employees. The company's products are marketed in Europe, North and South America, and Asia. For further information, visit the company's website at www.pharmaq.com
Did you know...
Newsfeed delivered by Meltwater News. PHARMAQ is not to be held liable for any of its content nor possible incorrect information given.
Pharmaq produserer vaksiner til 70 prosent av verdens laks
Europe Fish Vaccine Market 2020 Research on Import-Export Details, Business Standards and Forecast to 2025
Pharmaq recibe autorización para comercialización de nueva vacuna
Farmed Salmon is a Core Component of Healthy, Sustainable Diets
Har fått markedsføringstillatelse til ny vaksine - Kyst.no
Global Deltamethrin Market Analysis, Revenue, Share, Size, Developments, Feasibility Check
I denne bygda produserer de vaksiner til 70 prosent av verdens laks
FDA awards grants to help fund MUMS research
How Impact of Covid-19 on Single Drum Friability Testers market Development is Changing Business Needs?
Veterinary Vaccines Market : Facts, Figures and Analytical Insights 2020